HMC3 Microglia Cell Line Review: Applications in Neurodegenerative Disease

Lucia Buccarello authored a review article summarizing evidence on the HMC3 human microglial cell line, published on figshare under a CC-BY-4.0 license. The 631.3 KB PDF file, last updated in June 2026, integrates current evidence on the cell line's molecular and metabolic features, functional plasticity, and disease-oriented applications. It discusses how HMC3 cells model processes relevant to Alzheimer’s disease, Parkinson’s disease, ischemic injury, and metabolic neurodegeneration.

Use Cases

• Reviewing evidence on HMC3 cell line fidelity to human microglial biology based on the integrated literature.
• Identifying pharmacological and genetic interventions for microglial dysfunction based on the summarized repertoire.
• Designing neuron-microglia co-culture experiments based on the described impacts on neuronal vulnerability.
• Planning high-throughput or multi-omics discovery platforms based on the highlighted compatibility of HMC3 cells.

Strengths

• The 631.3 KB PDF file provides a structured review of a widely used experimental model.
• The content covers multiple neurodegenerative contexts, including Alzheimer’s and Parkinson’s disease.
• The dataset is published under a permissive CC-BY-4.0 license.

Limitations

• The dataset is a review article, not a primary data collection; row count and column-level documentation are absent.
• The file size of 631.3 KB indicates a limited scope, likely containing only the review text.
• Freshness should be verified as the last update was 2026-06-03.

Provenance

Source

figshare

Collection Method

Literature review authored by Lucia Buccarello.

Freshness

Last updated 2026-06-03 04:47:35; freshness should be verified.